Franklin Resources Inc. Purchases New Position in HilleVax, Inc. (NASDAQ:HLVX)
Franklin Resources Inc. Purchases New Position in HilleVax, Inc. (NASDAQ:HLVX)
Franklin Resources Inc. purchased a new stake in shares of HilleVax, Inc. (NASDAQ:HLVX – Get Rating) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 672,512 shares of the company's stock, valued at approximately $7,351,000. Franklin Resources Inc. owned approximately 2.01% of HilleVax as of its most recent SEC filing.
根據富蘭克林資源公司在提交給美國證券交易委員會(美國證券交易委員會)的最新Form 13F文件中，該公司在第二季度購買了HilleVax，Inc.(HLVX-GET Rating)的新股。該公司購買了672,512股該公司股票，價值約7,351,000美元。截至最近提交的美國證券交易委員會申請文件，富蘭克林資源公司持有HilleVax約2.01%的股份。
Other institutional investors and hedge funds also recently made changes to their positions in the company. Strs Ohio bought a new stake in HilleVax in the 2nd quarter worth approximately $32,000. TD Asset Management Inc. bought a new stake in HilleVax in the 2nd quarter worth approximately $203,000. Frazier Life Sciences Management L.P. bought a new stake in HilleVax in the 2nd quarter worth approximately $101,493,000. JPMorgan Chase & Co. bought a new stake in HilleVax in the 2nd quarter worth approximately $76,000. Finally, Alps Advisors Inc. bought a new stake in HilleVax in the 2nd quarter worth approximately $217,000.
其他機構投資者和對衝基金最近也對他們在該公司的頭寸進行了調整。俄亥俄州STRS在第二季度購買了HilleVax的新股份，價值約3.2萬美元。道明資產管理公司(TD Asset Management Inc.)在第二季度購入了價值約20.3萬美元的HilleVax新股份。弗雷澤生命科學管理公司在第二季度購買了HilleVax的新股份，價值約101,493,000美元。摩根大通在第二季度購入了價值約76,000美元的HilleVax新股份。最後，Alps Advisors Inc.在第二季度購入了價值約21.7萬美元的HilleVax新股份。
HilleVax Trading Up 4.9 %
HilleVax交易上漲4.9%
NASDAQ:HLVX opened at $20.00 on Thursday. The company has a quick ratio of 34.77, a current ratio of 34.77 and a debt-to-equity ratio of 0.02. HilleVax, Inc. has a 12 month low of $7.90 and a 12 month high of $24.42. The company has a 50 day simple moving average of $19.30 and a two-hundred day simple moving average of $14.99.
納斯達克：HLVX週四開盤報20.00美元。該公司的速動比率為34.77，流動比率為34.77，債務權益比為0.02。HilleVax，Inc.的12個月低點為7.90美元，12個月高位為24.42美元。該公司的50日簡單移動均線切入位在19.30美元，200日簡單移動均線切入位在14.99美元。
HilleVax Company Profile
HilleVax公司簡介
(Get Rating)
(獲取評級)
HilleVax, Inc, a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.
HilleVax，Inc.是一家臨牀階段的生物製藥公司，專注於開發和商業化新型疫苗。該公司正在開發HIL-214，這是一種基於病毒樣顆粒的候選疫苗，用於預防由諾沃克病毒感染引起的中到重度急性胃腸炎。該公司總部設在馬薩諸塞州波士頓。
Further Reading
進一步閲讀
- Get a free copy of the StockNews.com research report on HilleVax (HLVX)
- Will Easing Of Covid Rules Slash Risk For Chinese EV Maker NIO?
- Santa Claus Rally? Here's What Needs to Happen
- Cosmos Holdings May be a Long-Term Buy with Short-Term Risk
- Dark Clouds Are Gathering For Cloud Stocks
- 3 Dividend Growers With Good 2023 Growth Prospects
- 免費獲取StockNews.com關於HilleVax的研究報告(HLVX)
- 放寬Covid規則會降低中國電動汽車製造商蔚來的風險嗎？
- 聖誕老人拉力賽？以下是需要發生的事情
- Cosmos Holdings可能是具有短期風險的長期買入
- 烏雲雲集，雲股雲集
- 3個具有良好2023年增長前景的股息增長者
Want to see what other hedge funds are holding HLVX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HilleVax, Inc. (NASDAQ:HLVX – Get Rating).
想看看還有哪些對衝基金持有HLVX嗎？訪問HoldingsChannel.com獲取HilleVax，Inc.(納斯達克代碼：HLVX-GET Rating)的最新13F備案文件和內幕交易信息。
Receive News & Ratings for HilleVax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HilleVax and related companies with MarketBeat.com's FREE daily email newsletter.
接收HilleVax Daily的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對HilleVax和相關公司的最新新聞和分析師評級的每日簡要摘要。
譯文內容由第三人軟體翻譯。